iTeos Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 216213000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2023-06-30) |
| Status | current |
| Entity | iTeos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2e877af1-5f8b-47d1-b149-5cae3a6d9815
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-039341Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001808865/cash-and-equivalents/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2e877af1-5f8b-47d1-b149-5cae3a6d9815
History
- no predecessors — first report